BARTNIK; Eckart

Patent Applications and Registrations

Patent applications and USPTO patent grants for BARTNIK; Eckart.The latest application filed is for "expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor protein".

Company Profile

3.12.11

BARTNIK; Eckart - Frankfurt am Main DE
BARTNIK; Eckart - Paris FR
Bartnik; Eckart - Wiesbaden DE
Bartnik; Eckart - Wiesbaden-Delkenheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Expression And Folding In The Manufacturing Process Of Cd-rap By Using A Cd-rap Precursor Protein App 20200268663 - SCHOETTLE; Isabell ; et al.	2020-08-27
Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein Grant 10,660,852 - Schoettle , et al.	2020-05-26
Improvement Of Expression And Folding In The Manufacturing Process Of Cd-rap By Using A Cd-rap Precursor Protein App 20190046442 - SCHOETTLE; Isabell ; et al.	2019-02-14
Dotam Derivatives For Therapeutic Use App 20170050988 - HU; Hai-Yu ; et al.	2017-02-23
Use of PAK inhibitor for the treatment of a joint disease Grant 8,187,828 - Barradeau , et al. May 29, 2	2012-05-29
Use Of Pak Inhibitor For The Treatment Of A Joint Disease App 20090104279 - BARRADEAU; Sebastian ; et al.	2009-04-23
Use of Serum/Glucocorticoid-Regulated Kinase App 20080274487 - Bartnik; Eckart ; et al.	2008-11-06
Use of PAK inhibitor for the treatment of a joint disease Grant 7,364,887 - Barradeau , et al. April 29, 2	2008-04-29
Use of PAK inhibitor for the treatment of a joint disease App 20050037965 - Barradeau, Sebastian ; et al.	2005-02-17
Cyclic and heterocyclic N-substituted .alpha.-iminohydroxamic and -carboxylic acids Grant 6,815,440 - Thorwart , et al. November 9, 2	2004-11-09
5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists App 20040220148 - Stilz, Hans Ulrich ; et al.	2004-11-04
Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids App 20030176432 - Thorwart, Werner ; et al.	2003-09-18
Enoxaparin and methods of its use App 20020128226 - Kern, Christopher ; et al.	2002-09-12
Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use App 20020082246 - Schudok, Manfred ; et al.	2002-06-27
Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids App 20010011134 - Thorwart, Werner ; et al.	2001-08-02
Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use Grant 6,235,727 - Schudok , et al. May 22, 2	2001-05-22
Cyclic and heterocyclic N-substituted .alpha.-iminohydroxamic and carboxyclic acids Grant 6,207,672 - Thorwart , et al. March 27, 2	2001-03-27
Carbohydrate mimetics having antiadhesive properties Grant 6,136,790 - Toepfer , et al. October 24, 2	2000-10-24
Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems Grant 5,872,209 - Bartnik , et al. February 16, 1	1999-02-16
Carbohydrate conjugates as inhibitors of cell adhesion Grant 5,858,994 - Kretzschmar , et al. January 12, 1	1999-01-12
Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents Grant 5,817,742 - Toepfer , et al. October 6, 1	1998-10-06
Multiply fucosylated dicarboxylic acids possessing antiadhesive properties Grant 5,811,405 - Toepfer , et al. September 22, 1	1998-09-22
Malonic acid derivatives having antiadhesive properties Grant 5,693,621 - Toepfer , et al. December 2, 1	1997-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.